Global Hydroxyzine Market Growth 2024-2030

Global Hydroxyzine Market Growth 2024-2030

Hydroxyzine is used to treat itching caused by allergies. It is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Hydroxyzine may also be used short-term to treat anxiety or to help you feel sleepy/relaxed before and after surgery.

The global Hydroxyzine market size is projected to grow from US$ 258 million in 2024 to US$ 348 million in 2030; it is expected to grow at a CAGR of 5.1% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Hydroxyzine Industry Forecast” looks at past sales and reviews total world Hydroxyzine sales in 2023, providing a comprehensive analysis by region and market sector of projected Hydroxyzine sales for 2024 through 2030. With Hydroxyzine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hydroxyzine industry.

This Insight Report provides a comprehensive analysis of the global Hydroxyzine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hydroxyzine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hydroxyzine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hydroxyzine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hydroxyzine.

United States market for Hydroxyzine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Hydroxyzine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Hydroxyzine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Hydroxyzine players cover Teva Pharmaceuticals, Pfizer, GSK, Alliance Pharma, Piramal Group (Piramal Healthcare UK Limited), etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Hydroxyzine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Tablets
Capsules
Other

Segmentation by Application:
Retail Pharmacy
Hospitals

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Teva Pharmaceuticals
Pfizer
GSK
Alliance Pharma
Piramal Group (Piramal Healthcare UK Limited)
Impax Laboratories
Novartis
Shanghai Ruizheng Chemical Technology
N&R Industries

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hydroxyzine market?

What factors are driving Hydroxyzine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hydroxyzine market opportunities vary by end market size?

How does Hydroxyzine break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver. Show more